Zhejiang University: Carcinoma, Hepatocellular trials

The registry lists 34 Carcinoma, Hepatocellular studies with Zhejiang University as lead sponsor. 8 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 8Phase 2 11Phase 3 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Safety and Efficacy of Metabolically Armed GPC3 CAR-T Cells Injection (Meta10-GPC3) in Patients With Unresectable Recurrent/Metastatic Hepatocellular CarcinomaNot yet recruitingNCT07487402Early Phase 1
• Laryngopharyngeal Injury After Endotracheal Intubation Under General AnesthesiaRecruitingNCT07359586
• Personalized Tumor Neoantigen mRNA Therapy for Advanced Hepatocellular CarcinomaRecruitingNCT06995105Phase 1/2
• Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)Not yet recruitingNCT06928415
• Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular CarcinomaRecruitingNCT06461624Phase 1
• Impact of "No-touch" Technique on the Outcome of Liver Transplantation for Hepatocellular CarcinomaNot yet recruitingNCT06331273
• Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular CarcinomaNot yet recruitingNCT06331260
• A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular CarcinomaRecruitingNCT05155189Phase 1
• Artificially Intelligent Model for Accurate Detection of HCCCompletedNCT06637059
• Survival Analysis: TACE vs. Combination Therapy in HCCCompletedNCT06261138
• Hepatitis B Virus Reactivation: a Cautionary Event After Liver Transplantation for Patients With Hepatocellular CarcinomaCompletedNCT06114251
• Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular CarcinomaCompletedNCT05907772
• Prognostic Models for HCC Based on Tumor MicronecrosisStatus unknownNCT05837065
• HCC Staging Modified by Tumor MicronecrosisCompletedNCT05739110
• Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular CarcinomaCompletedNCT05643833
• Effect of Tumor Micronecrosis on Postoperative Transcatheter Arterial Chemoembolization in Patients With Hepatocellular CarcinomasCompletedNCT05352204
• Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular CarcinomaStatus unknownNCT05312216Phase 2
• Study on Therapeutic Effect of Combination of Envafolimab, Lenavatinib and TACE in Advanced HCC PatientsCompletedNCT05213221Phase 2
• A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative ResectionStatus unknownNCT04981665Phase 2
• SHR-1210 Combined With Apatinib Mesylate in the Perioperative Therapy for Hepatocellular CarcinomaCompletedNCT04930315Phase 2
• Perioperative Therapy for Hepatocellular CarcinomaTerminatedNCT04653389Phase 2
• Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC PatientsCompletedNCT04418401Phase 1
• AFP Specific T Cell Receptor Transduced T Cells Injection(C-TCR055) in Unresectable Hepatocellular CarcinomaStatus unknownNCT04368182Phase 1
• Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCCStatus unknownNCT04174781Phase 2
• Combination Camrelizumab (SHR-1210) and Apatinib for Downstaging/Bridging of HCC Before Liver TransplantStatus unknownNCT04035876Phase 1/2
• Multi-center Clinical Application of Hangzhou Criteria in Liver Transplantation for Hepatocellular CarcinomaStatus unknownNCT03985644
• Radiomics-based Non-invasive Classifier Research for HCC-related Liver TransplantationStatus unknownNCT03981848
• 4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3CompletedNCT03980288Phase 1
• A Multicenter Study of Anlotinib in Hepatocellular Carcinoma (HCC) Patients at High Risk of Post Surgery RecurrenceTerminatedNCT03945799Phase 1/2
• Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center and Prospective StudyStatus unknownNCT03708705
• Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular CarcinomaStatus unknownNCT03668158
• Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver TransplantationWithdrawnNCT02580253Phase 2
• Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1WithdrawnNCT02129322Phase 2
• Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular CarcinomaCompletedNCT02109146Phase 3